CD14 and breast cancer: On the other hand, non-classical monocytes (CD3Neg CD14+ CD16High) tended to decrease with DOX and to increase with PLX in both subtypes showing significant difference against the 6th NAC cycle in the ER+ BC subtype (Figure 4C).